Paragon Care Limited (ASX:PGC)
0.3150
-0.0050 (-1.56%)
Nov 13, 2025, 4:10 PM AEST
Paragon Care Revenue
In the fiscal year ending June 30, 2025, Paragon Care had annual revenue of 3.61B AUD with 21.68% growth. Paragon Care had revenue of 1.76B in the half year ending June 30, 2025.
Revenue
3.61B
Revenue Growth
+21.68%
P/S Ratio
0.14
Revenue / Employee
6.57M
Employees
550
Market Cap
521.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.61B | 644.00M | 21.68% |
| Jun 30, 2024 | 2.97B | 782.54M | 35.78% |
| Jun 30, 2023 | 2.19B | 479.19M | 28.05% |
| Jun 30, 2022 | 1.71B | 91.10M | 5.63% |
| Jun 30, 2021 | 1.62B | 68.44M | 4.42% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |